Ask an Expert: Affinity Credit Union. In this segment they're helping you navigate the world of fixed and variable rate mortgages #sponsoredcontent CTV News App Contact Us FAQ Newsletters Team ...

as well as the performances of multiple sclerosis therapy Ocrevus (ocrelizumab) and Hemlibra (emicizumab) for haemophilia. Diagnostic led the charge, rising 24% to CHF 5.3 billion, but pharma also ...

Code repo for winning 2016 MSCOCO Keypoints Challenge, 2016 ECCV Best Demo Award, and 2017 CVPR Oral paper. Watch our video result in YouTube or our website.

That could give the drugs an advantage over CD20-targeting therapies like Roche's Ocrevus (ocrelizumab) that inhibit B cells across the board, leaving patients prone to infections and other side ...

The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was particularly heightened among patients with severe mucous membrane pemphigoid.

The study, called MoonStone (NCT06564311), is open to… Less frequent Ocrevus (ocrelizumab) infusions are as effective as standard dosing — when treatment is given typically every six months ...

这篇综述系统探讨了多发性硬化症(MS)患者停用疾病修饰治疗(DMT)的临床决策难题。文章整合了DISCOMS和DOT-MS等随机对照试验数据，指出高龄(>55岁)且病情稳定(5年无复发)患者可考虑停用一线DMT，但需警惕细胞迁移抑制剂(如natalizumab)停药后的复发风险。特别强调了 ...

Anti-CD20 monoclonal antibodies (MAbs) are targeted therapies primarily to treat B-cell neoplasias such as non-Hodgkin lymphoma and chronic lymphocytic leukemia. CD20 is a surface antigen expressed on ...